# Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection

> **NCT01273142** · — · UNKNOWN · sponsor: **Henan Provincial People's Hospital** · enrollment: 100 (estimated)

## Conditions studied

- HIV Infections
- Liver Toxicity
- Hepatitis Co-infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01273142
- **Lead sponsor:** Henan Provincial People's Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273142

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273142, "Compare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infection". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01273142. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*